LIVN Stock Analysis: Buy, Sell, or Hold?
LIVN - LivaNova PLC Ordinary Shares
$63.79
-0.84 (-1.30%)
▼
5d:
+0.22%
30d:
-2.25%
90d:
+3.67%
BUY
HIGH Confidence
Analysis Updated: Apr 2, 2026 12:00 AM ET
Earnings: May 06, 2026
Smart Money Accumulation
LIVN is down 8.3% this week, but smart money is accumulating calls. Top strike: $67.5 2026-04-17 with 1 OI. Call ratio: 100% View Scanner →
Strength: 9.2/10
Get Alerted When LIVN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: LIVN shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
✅ BUY SIGNAL: LIVN shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$92.69
Based on 6.4% avg growth
INTRINSIC VALUE TODAY
$57.55
Trading above fair value
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 14.9x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: LIVN is currently trading at $63.79, which is considered fair relative to its 30-day fair value range of $60.98 to $67.71. The stock's valuation (Forward PE: 13.9) is in line with its historical norms (14.9). Remarkably, the market is currently pricing in an annual earnings decline of 2.3% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, LIVN is in a uptrend. The price is approaching resistance at $65.21. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: LIVN has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $79.91 (+25.3%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, LIVN is in a uptrend. The price is approaching resistance at $65.21. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: LIVN has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $79.91 (+25.3%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Fair Price Range
$60.98 -
$67.71
Company Quality Score
53/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
86.5%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Options cheap (IV 0th percentile)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 25.3% below Wall St target ($79.91)
Fair Price Analysis
30-Day Fair Range
$60.98 -
$67.71
Current vs Fair Value
FAIR
Expected Move (7 Days)
±$4.51
(7.1%)
Support & Resistance Levels
Support Level
$60.35
Resistance Level
$65.21
Current Trend
Uptrend
Technical data as of
Apr 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
13.94
Wall Street Target
$79.91
(+25.3%)
Revenue Growth (YoY)
12.1%
Earnings Growth (YoY)
-45.6%
Profit Margin
-17.5%
Valuation Discount vs History
-2.3% cheaper
PE vs Historical
13.9 vs 14.9
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-2.3%
(market-implied from PE analysis)
1-Year Target
$62.32
(-2%)
2-Year Target
$60.89
(-5%)
3-Year Target
$59.49
(-7%)
3-Yr Target (if PE normalizes)
(PE: 14→15)
$63.57
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.6, Growth: 8.7%)
$120.92
(+90%)
Base:
(SPY PE: 13.9, Growth: 8.7%)
$81.96
(+29%)
Bear:
(PE: 11.9, Growth: 8.7%)
$69.67
(+9%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 13.9 to 14.9
Stabilization Target:
$68.17
(+6.9%)
PE Expansion Potential:
+6.9%
Share & Embed Analysis
Last updated: April 02, 2026 5:46 PM ET
Data refreshes hourly during market hours. Next update: 6:46 PM
Data refreshes hourly during market hours. Next update: 6:46 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is LIVN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SYK
Stryker Corporation |
BUY
32 analysts |
$424 | 61 BUY |
|
ABT
Abbott Laboratories |
BUY
28 analysts |
$133 | 59 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$111 | 62 BUY |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$96 | 56 HOLD |
|
GEHC
GE HealthCare Technologi… |
STRONG BUY
21 analysts |
$93 | 62 BUY |
Advanced LIVN Option Strategies
Professional options setups generated by AI based on today's LIVN price and gamma walls.
